Magnoflorine iodide

CAS No. 4277-43-4

Magnoflorine iodide( —— )

Catalog No. M18544 CAS No. 4277-43-4

Magnoflorine has anti-inflammatory activity, it can inhibit inflammations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 64 In Stock
2MG 38 In Stock
5MG 61 In Stock
10MG 93 In Stock
25MG 177 In Stock
50MG 257 In Stock
100MG 369 In Stock
200MG 556 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Magnoflorine iodide
  • Note
    Research use only, not for human use.
  • Brief Description
    Magnoflorine has anti-inflammatory activity, it can inhibit inflammations.
  • Description
    Magnoflorine has anti-inflammatory activity, it can inhibit inflammations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4277-43-4
  • Formula Weight
    469.31
  • Molecular Formula
    C20H24INO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (133.17 mM)
  • SMILES
    C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)O)OC)C.[I-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Selisistat S-enantio...

    EX-527 S-enantiomer is the S-enantiomer of EX-527,with an IC50 of 123 nM for SIRT1.

  • JGB1741

    JGB1741 is a potent and selective inhibitor of SIRT1 with an IC50 of 15 μM. JGB1741 modulates Bax/Bcl2 ratio, cytochrome c release and PARP cleavage and increases the acetylated p53 levels leading to p53-mediated apoptosis. JGB1741 can be used in studies about breast cancer.

  • Pristimerin

    Pristimerin has anticancer activity, treatment with Pristimerin may be a potential strategy for the suppression of hypoxia-induced metastasis through the reversal of hypoxia-induced stem cell characteristics and EMT in cancer cells.